Tejara Capital’s Teva Pharmaceuticals TEVA Stock Holding History

Tejara Capital’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-78,500	Closed	-$1.32M	–	74
2025 Q2	$1.32M	Sell	78,500 -102,300	-57%	-$1.65M	0.61%	47
2025 Q1	$2.78M	Buy	+180,800	New	+$3.23M	1.37%	28
2024 Q3	–	Sell	-418,588	Closed	-$6.8M	–	74
2024 Q2	$6.8M	Sell	418,588 -361,618	-46%	-$5.57M	2.48%	15
2024 Q1	$11M	Sell	780,206 -275,800	-26%	-$3.48M	4.08%	6
2023 Q4	$11M	Buy	1,056,006 +233,511	+28%	+$2.18M	4.62%	3
2023 Q3	$8.39M	Buy	822,495 +293,900	+56%	+$2.74M	4.77%	5
2023 Q2	$3.98M	Buy	+528,595	New	+$4.29M	1.96%	15

Other funds holding TEVA

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.5B AUM 68.34% 1-Year Est. Return

Lingotto Investment Management London, United Kingdom $5.04B AUM 91.14% 1-Year Est. Return

Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PointState Capital New York $4.31B AUM 42.31% 1-Year Est. Return